APO Research
Talk to an analyst

APO RESEARCH · REPORT

NAD+ Enhancer

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global NAD+ Enhancer Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchNAD+ Enhancer Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NAD+ Enhancer Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal NAD+ Enhancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NAD+ Enhancer Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal NAD+ Enhancer Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global NAD+ Enhancer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NAD+ Enhancer market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NAD+ Enhancer market include EffePharm, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), GeneHarbor, NOMON Co., Ltd. (Teijin), Maac10 Formulas, Kingdomway, Herbalmax, Genex Formulas and EZZ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NAD+ Enhancer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NAD+ Enhancer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NAD+ Enhancer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NAD+ Enhancer market size, projected growth trends, production technologies, key applications, and end-use industries.

NAD+ Enhancer Segment by Company

EffePharm

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

GeneHarbor

NOMON Co., Ltd. (Teijin)

Maac10 Formulas

Kingdomway

Herbalmax

Genex Formulas

EZZ

Elysium Health

Chromadex

CELFULL

Bontac

NAD+ Enhancer Segment by Type

Content ＜98%

Content ≥98%

NAD+ Enhancer Segment by Application

Health Care Products

ClinicsBeauty Products

Others

NAD+ Enhancer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global NAD+ Enhancer status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions NAD+ Enhancer market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NAD+ Enhancer significant trends, drivers, influence factors in global and regions.

6. To analyze NAD+ Enhancer competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Enhancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NAD+ Enhancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Enhancer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NAD+ Enhancer market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NAD+ Enhancer industry.

Chapter 3: Detailed analysis of NAD+ Enhancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of NAD+ Enhancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of NAD+ Enhancer in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NAD+ Enhancer Industry Trends Table 2. NAD+ Enhancer Industry Drivers Table 3. NAD+ Enhancer Industry Opportunities and Challenges Table 4. NAD+ Enhancer Industry Restraints Table 5. Global NAD+ Enhancer Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NAD+ Enhancer Revenue Share by Company (2021-2026) Table 7. Global NAD+ Enhancer Sales Volume by Company (K Units) & (2021-2026) Table 8. Global NAD+ Enhancer Sales Volume Share by Company (2021-2026) Table 9. Global NAD+ Enhancer Average Price (US$/Unit) of Company (2021-2026) Table 10. Global NAD+ Enhancer Company Ranking, (2024-2026) & (USD Million) Table 11. Global NAD+ Enhancer Key Company Manufacturing Base & Headquarters Table 12. Global NAD+ Enhancer Company, Product Type & Application Table 13. Global NAD+ Enhancer Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global NAD+ Enhancer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Content ＜98% Table 18. Significant Companies of Content ≥98% Table 19. Global NAD+ Enhancer Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global NAD+ Enhancer Sales Volume by Type (2021-2026) & (K Units) Table 21. Global NAD+ Enhancer Sales Volume by Type (2027-2032) & (K Units) Table 22. Global NAD+ Enhancer Sales Volume Share by Type (2021-2026) Table 23. Global NAD+ Enhancer Sales Volume Share by Type (2027-2032) Table 24. Global NAD+ Enhancer Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global NAD+ Enhancer Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global NAD+ Enhancer Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global NAD+ Enhancer Sales Value Share by Type (2021-2026) Table 28. Global NAD+ Enhancer Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Health Care Products Table 30. Significant Companies of ClinicsBeauty Products Table 31. Significant Companies of Others Table 32. Global NAD+ Enhancer Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global NAD+ Enhancer Sales Volume by Application (2021-2026) & (K Units) Table 34. Global NAD+ Enhancer Sales Volume by Application (2027-2032) & (K Units) Table 35. Global NAD+ Enhancer Sales Volume Share by Application (2021-2026) Table 36. Global NAD+ Enhancer Sales Volume Share by Application (2027-2032) Table 37. Global NAD+ Enhancer Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global NAD+ Enhancer Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global NAD+ Enhancer Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global NAD+ Enhancer Sales Value Share by Application (2021-2026) Table 41. Global NAD+ Enhancer Sales Value Share by Application (2027-2032) Table 42. Global NAD+ Enhancer Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global NAD+ Enhancer Sales by Region (2021-2026) & (K Units) Table 44. Global NAD+ Enhancer Sales Market Share by Region (2021-2026) Table 45. Global NAD+ Enhancer Sales by Region (2027-2032) & (K Units) Table 46. Global NAD+ Enhancer Sales Market Share by Region (2027-2032) Table 47. Global NAD+ Enhancer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global NAD+ Enhancer Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global NAD+ Enhancer Sales Value Share by Region (2021-2026) Table 50. Global NAD+ Enhancer Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global NAD+ Enhancer Sales Value Share by Region (2027-2032) Table 52. Global NAD+ Enhancer Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global NAD+ Enhancer Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global NAD+ Enhancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global NAD+ Enhancer Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 57. Global NAD+ Enhancer Sales Market Share by Country (2021-2026) Table 58. Global NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 59. Global NAD+ Enhancer Sales Market Share by Country (2027-2032) Table 60. Global NAD+ Enhancer Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global NAD+ Enhancer Sales Value Market Share by Country (2021-2026) Table 62. Global NAD+ Enhancer Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global NAD+ Enhancer Sales Value Market Share by Country (2027-2032) Table 64. EffePharm Company Information Table 65. EffePharm Business Overview Table 66. EffePharm NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. EffePharm NAD+ Enhancer Product Portfolio Table 68. EffePharm Recent Development Table 69. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information Table 70. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview Table 71. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio Table 73. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development Table 74. GeneHarbor Company Information Table 75. GeneHarbor Business Overview Table 76. GeneHarbor NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GeneHarbor NAD+ Enhancer Product Portfolio Table 78. GeneHarbor Recent Development Table 79. NOMON Co., Ltd. (Teijin) Company Information Table 80. NOMON Co., Ltd. (Teijin) Business Overview Table 81. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio Table 83. NOMON Co., Ltd. (Teijin) Recent Development Table 84. Maac10 Formulas Company Information Table 85. Maac10 Formulas Business Overview Table 86. Maac10 Formulas NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Maac10 Formulas NAD+ Enhancer Product Portfolio Table 88. Maac10 Formulas Recent Development Table 89. Kingdomway Company Information Table 90. Kingdomway Business Overview Table 91. Kingdomway NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Kingdomway NAD+ Enhancer Product Portfolio Table 93. Kingdomway Recent Development Table 94. Herbalmax Company Information Table 95. Herbalmax Business Overview Table 96. Herbalmax NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Herbalmax NAD+ Enhancer Product Portfolio Table 98. Herbalmax Recent Development Table 99. Genex Formulas Company Information Table 100. Genex Formulas Business Overview Table 101. Genex Formulas NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Genex Formulas NAD+ Enhancer Product Portfolio Table 103. Genex Formulas Recent Development Table 104. EZZ Company Information Table 105. EZZ Business Overview Table 106. EZZ NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. EZZ NAD+ Enhancer Product Portfolio Table 108. EZZ Recent Development Table 109. Elysium Health Company Information Table 110. Elysium Health Business Overview Table 111. Elysium Health NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Elysium Health NAD+ Enhancer Product Portfolio Table 113. Elysium Health Recent Development Table 114. Chromadex Company Information Table 115. Chromadex Business Overview Table 116. Chromadex NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Chromadex NAD+ Enhancer Product Portfolio Table 118. Chromadex Recent Development Table 119. CELFULL Company Information Table 120. CELFULL Business Overview Table 121. CELFULL NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. CELFULL NAD+ Enhancer Product Portfolio Table 123. CELFULL Recent Development Table 124. Bontac Company Information Table 125. Bontac Business Overview Table 126. Bontac NAD+ Enhancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Bontac NAD+ Enhancer Product Portfolio Table 128. Bontac Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. NAD+ Enhancer Distributors List Table 132. NAD+ Enhancer Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. NAD+ Enhancer Product Image Figure 2. Global NAD+ Enhancer Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NAD+ Enhancer Sales Value (2021-2032) & (US$ Million) Figure 4. Global NAD+ Enhancer Sales (2021-2032) & (K Units) Figure 5. Global NAD+ Enhancer Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global NAD+ Enhancer Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Content ＜98% Image Figure 10. Content ≥98% Image Figure 11. Global NAD+ Enhancer Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global NAD+ Enhancer Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global NAD+ Enhancer Sales Volume Share by Type (2021-2032) Figure 14. Global NAD+ Enhancer Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global NAD+ Enhancer Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global NAD+ Enhancer Sales Value Share by Type (2021-2032) Figure 17. Health Care Products Image Figure 18. ClinicsBeauty Products Image Figure 19. Others Image Figure 20. Global NAD+ Enhancer Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global NAD+ Enhancer Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global NAD+ Enhancer Sales Volume Share by Application (2021-2032) Figure 23. Global NAD+ Enhancer Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global NAD+ Enhancer Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global NAD+ Enhancer Sales Value Share by Application (2021-2032) Figure 26. Global NAD+ Enhancer Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global NAD+ Enhancer Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global NAD+ Enhancer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global NAD+ Enhancer Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America NAD+ Enhancer Sales Value (2021-2032) & (US$ Million) Figure 31. North America NAD+ Enhancer Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe NAD+ Enhancer Sales Value (2021-2032) & (US$ Million) Figure 33. Europe NAD+ Enhancer Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific NAD+ Enhancer Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific NAD+ Enhancer Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America NAD+ Enhancer Sales Value (2021-2032) & (US$ Million) Figure 37. South America NAD+ Enhancer Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa NAD+ Enhancer Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa NAD+ Enhancer Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt NAD+ Enhancer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. NAD+ Enhancer Value Chain Figure 125. Manufacturing Cost Structure Figure 126. NAD+ Enhancer Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Content ＜98%
  • Content ≥98%
Applications
  • Health Care Products
  • ClinicsBeauty Products
  • Others
Companies covered
  • EffePharm
  • Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  • GeneHarbor
  • NOMON Co., Ltd. (Teijin)
  • Maac10 Formulas
  • Kingdomway
  • Herbalmax
  • Genex Formulas
  • EZZ
  • Elysium Health
  • Chromadex
  • CELFULL
  • Bontac

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NAD+ Enhancer Sales Value (2021-2032)
  4. 1.2.2 Global NAD+ Enhancer Sales Volume (2021-2032)
  5. 1.2.3 Global NAD+ Enhancer Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 NAD+ Enhancer Market Dynamics
  1. 2.1 NAD+ Enhancer Industry Trends
  2. 2.2 NAD+ Enhancer Industry Drivers
  3. 2.3 NAD+ Enhancer Industry Opportunities and Challenges
  4. 2.4 NAD+ Enhancer Industry Restraints
3 NAD+ Enhancer Market by Company
  1. 3.1 Global NAD+ Enhancer Company Revenue Ranking in 2025
  2. 3.2 Global NAD+ Enhancer Revenue by Company (2021-2026)
  3. 3.3 Global NAD+ Enhancer Sales Volume by Company (2021-2026)
  4. 3.4 Global NAD+ Enhancer Average Price by Company (2021-2026)
  5. 3.5 Global NAD+ Enhancer Company Ranking (2024-2026)
  6. 3.6 Global NAD+ Enhancer Company Manufacturing Base and Headquarters
  7. 3.7 Global NAD+ Enhancer Company Product Type and Application
  8. 3.8 Global NAD+ Enhancer Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global NAD+ Enhancer Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 NAD+ Enhancer Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 NAD+ Enhancer Market by Type
  1. 4.1 NAD+ Enhancer Type Introduction
  2. 4.1.1 Content ＜98%
  3. 4.1.2 Content ≥98%
  4. 4.2 Global NAD+ Enhancer Sales Volume by Type
  5. 4.2.1 Global NAD+ Enhancer Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global NAD+ Enhancer Sales Volume by Type (2021-2032)
  7. 4.2.3 Global NAD+ Enhancer Sales Volume Share by Type (2021-2032)
  8. 4.3 Global NAD+ Enhancer Sales Value by Type
  9. 4.3.1 Global NAD+ Enhancer Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global NAD+ Enhancer Sales Value by Type (2021-2032)
  11. 4.3.3 Global NAD+ Enhancer Sales Value Share by Type (2021-2032)
5 NAD+ Enhancer Market by Application
  1. 5.1 NAD+ Enhancer Application Introduction
  2. 5.1.1 Health Care Products
  3. 5.1.2 ClinicsBeauty Products
  4. 5.1.3 Others
  5. 5.2 Global NAD+ Enhancer Sales Volume by Application
  6. 5.2.1 Global NAD+ Enhancer Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NAD+ Enhancer Sales Volume by Application (2021-2032)
  8. 5.2.3 Global NAD+ Enhancer Sales Volume Share by Application (2021-2032)
  9. 5.3 Global NAD+ Enhancer Sales Value by Application
  10. 5.3.1 Global NAD+ Enhancer Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NAD+ Enhancer Sales Value by Application (2021-2032)
  12. 5.3.3 Global NAD+ Enhancer Sales Value Share by Application (2021-2032)
6 NAD+ Enhancer Regional Sales and Value Analysis
  1. 6.1 Global NAD+ Enhancer Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NAD+ Enhancer Sales by Region (2021-2032)
  3. 6.2.1 Global NAD+ Enhancer Sales by Region: 2021-2026
  4. 6.2.2 Global NAD+ Enhancer Sales by Region (2027-2032)
  5. 6.3 Global NAD+ Enhancer Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global NAD+ Enhancer Sales Value by Region (2021-2032)
  7. 6.4.1 Global NAD+ Enhancer Sales Value by Region: 2021-2026
  8. 6.4.2 Global NAD+ Enhancer Sales Value by Region (2027-2032)
  9. 6.5 Global NAD+ Enhancer Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America NAD+ Enhancer Sales Value (2021-2032)
  12. 6.6.2 North America NAD+ Enhancer Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe NAD+ Enhancer Sales Value (2021-2032)
  15. 6.7.2 Europe NAD+ Enhancer Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific NAD+ Enhancer Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific NAD+ Enhancer Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America NAD+ Enhancer Sales Value (2021-2032)
  21. 6.9.2 South America NAD+ Enhancer Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa NAD+ Enhancer Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa NAD+ Enhancer Sales Value Share by Country, 2025 VS 2032
7 NAD+ Enhancer Country-level Sales and Value Analysis
  1. 7.1 Global NAD+ Enhancer Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NAD+ Enhancer Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global NAD+ Enhancer Sales by Country (2021-2032)
  4. 7.3.1 Global NAD+ Enhancer Sales by Country (2021-2026)
  5. 7.3.2 Global NAD+ Enhancer Sales by Country (2027-2032)
  6. 7.4 Global NAD+ Enhancer Sales Value by Country (2021-2032)
  7. 7.4.1 Global NAD+ Enhancer Sales Value by Country (2021-2026)
  8. 7.4.2 Global NAD+ Enhancer Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt NAD+ Enhancer Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt NAD+ Enhancer Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt NAD+ Enhancer Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 EffePharm
  2. 8.1.1 EffePharm Company Information
  3. 8.1.2 EffePharm Business Overview
  4. 8.1.3 EffePharm NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 EffePharm NAD+ Enhancer Product Portfolio
  6. 8.1.5 EffePharm Recent Developments
  7. 8.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  8. 8.2.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
  9. 8.2.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
  10. 8.2.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio
  12. 8.2.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
  13. 8.3 GeneHarbor
  14. 8.3.1 GeneHarbor Company Information
  15. 8.3.2 GeneHarbor Business Overview
  16. 8.3.3 GeneHarbor NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GeneHarbor NAD+ Enhancer Product Portfolio
  18. 8.3.5 GeneHarbor Recent Developments
  19. 8.4 NOMON Co., Ltd. (Teijin)
  20. 8.4.1 NOMON Co., Ltd. (Teijin) Company Information
  21. 8.4.2 NOMON Co., Ltd. (Teijin) Business Overview
  22. 8.4.3 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio
  24. 8.4.5 NOMON Co., Ltd. (Teijin) Recent Developments
  25. 8.5 Maac10 Formulas
  26. 8.5.1 Maac10 Formulas Company Information
  27. 8.5.2 Maac10 Formulas Business Overview
  28. 8.5.3 Maac10 Formulas NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Maac10 Formulas NAD+ Enhancer Product Portfolio
  30. 8.5.5 Maac10 Formulas Recent Developments
  31. 8.6 Kingdomway
  32. 8.6.1 Kingdomway Company Information
  33. 8.6.2 Kingdomway Business Overview
  34. 8.6.3 Kingdomway NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kingdomway NAD+ Enhancer Product Portfolio
  36. 8.6.5 Kingdomway Recent Developments
  37. 8.7 Herbalmax
  38. 8.7.1 Herbalmax Company Information
  39. 8.7.2 Herbalmax Business Overview
  40. 8.7.3 Herbalmax NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Herbalmax NAD+ Enhancer Product Portfolio
  42. 8.7.5 Herbalmax Recent Developments
  43. 8.8 Genex Formulas
  44. 8.8.1 Genex Formulas Company Information
  45. 8.8.2 Genex Formulas Business Overview
  46. 8.8.3 Genex Formulas NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Genex Formulas NAD+ Enhancer Product Portfolio
  48. 8.8.5 Genex Formulas Recent Developments
  49. 8.9 EZZ
  50. 8.9.1 EZZ Company Information
  51. 8.9.2 EZZ Business Overview
  52. 8.9.3 EZZ NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 EZZ NAD+ Enhancer Product Portfolio
  54. 8.9.5 EZZ Recent Developments
  55. 8.10 Elysium Health
  56. 8.10.1 Elysium Health Company Information
  57. 8.10.2 Elysium Health Business Overview
  58. 8.10.3 Elysium Health NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Elysium Health NAD+ Enhancer Product Portfolio
  60. 8.10.5 Elysium Health Recent Developments
  61. 8.11 Chromadex
  62. 8.11.1 Chromadex Company Information
  63. 8.11.2 Chromadex Business Overview
  64. 8.11.3 Chromadex NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Chromadex NAD+ Enhancer Product Portfolio
  66. 8.11.5 Chromadex Recent Developments
  67. 8.12 CELFULL
  68. 8.12.1 CELFULL Company Information
  69. 8.12.2 CELFULL Business Overview
  70. 8.12.3 CELFULL NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CELFULL NAD+ Enhancer Product Portfolio
  72. 8.12.5 CELFULL Recent Developments
  73. 8.13 Bontac
  74. 8.13.1 Bontac Company Information
  75. 8.13.2 Bontac Business Overview
  76. 8.13.3 Bontac NAD+ Enhancer Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bontac NAD+ Enhancer Product Portfolio
  78. 8.13.5 Bontac Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NAD+ Enhancer Value Chain Analysis
  2. 9.1.1 NAD+ Enhancer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NAD+ Enhancer Sales Mode & Process
  6. 9.2 NAD+ Enhancer Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NAD+ Enhancer Distributors
  9. 9.2.3 NAD+ Enhancer Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst